Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single Dose of SAR441344 in Healthy Adult Subjects

Trial Identifier:	TDR15526
Sponsor:	Sanofi
NCTID::	NCT05845996
Start Date:	February 2019
Study Completion Date:	April 2020
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States	United States

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.